Your browser does not support JavaScript!
Yang WH, Su YH, Hsu WH, Wang CC, Arbiser JL*, Yang MH*. Imipramine blue halts head and neck cancer invasion through promoting F-box and leucine-rich repeat protein 14-mediated Twist1 degradation. Onco

Yang WH, Su YH, Hsu WH, Wang CC, Arbiser JL*, Yang MH*. Imipramine blue halts head and neck cancer invasion through promoting F-box and leucine-rich repeat protein 14-mediated Twist1 degradation.Oncogene 2015 DOI: 10.1038/onc.2015.291 (*: co-corresponding authors)

Abstract
 

The unique characteristic of head and neck squamous cell carcinoma (HNSCC) is that local invasion rather than distant metastasis is the major route for dissemination. Therefore, targeting the locally invasive cancer cells is more important than preventing systemic metastasis in HNSCC and other invasive-predominant cancers. We previously demonstrate a specific mechanism for HNSCC local invasion: the epithelial-mesenchymal transition (EMT) regulator Twist1 represses microRNA let-7i expression, which leads to the activation of the small GTPase Rac1 and engendering the mesenchymal-mode movement in 3D culture. However, targeting the EMT regulator is relatively difficult due to its transcription factor nature and the strategy for confining HNSCC invasion to facilitate local treatment is limited. Imipramine blue (IB) is a newly identified anti-invasive compound that effectively inhibits glioma invasion. Here we demonstrate that in HNSCC cells, a non-cytotoxic dose of IB represses mesenchymal-mode migration in 2.5D/3D culture system. IB suppresses EMT and stemness of HNSCC cells through inhibition of Twist1-mediated let-7i downregulation and Rac1 activation and the EMT signalling. Mechanistically, IB inhibits reactive oxygen species-induced NF-kB pathway activation. Importantly, IB promotes degradation of the EMT inducer Twist1 by enhancing F-box and leucine-rich repeat protein 14 (FBXL14)-mediated polyubiquitination of Twist1. Together, this study demonstrates the potent anti-invasion and EMT-inhibition effect of IB, suggesting the potential of IB in treating local invasion-predominant cancers.

瀏覽數  
將此文章推薦給親友
請輸入此驗證碼
Voice Play
更換驗證碼